(PRWEB) April 27, 2015 -- The blood culture test market is categorized on the basis of methods, products, applications, end users and regions. Factors such as increasing demand for rapid diagnostic techniques, high prevalence of infectious diseases, increase in healthcare expenditure and rising aging population are driving the growth of this market. Moreover, increasing blood stream infections (BSI) is another major factor propelling the growth of this market. According to the U.S. CDC (Centres for Disease Control and Prevention), catheter-related blood stream infection (CRBSI) is the most common cause for healthcare-associated blood stream infection. Around 12% to 25% of patients who acquire BSI die every year while some of them have to prolong their hospital stay leading to increase in the overall treatment cost. A treatment of CRBSI can cost up to $56,000, once the cost of pharmacy increases, the cost of catheter and additional diagnostic tests also increases which leads to the increase in the overall healthcare cost.
Inquiries on This Report @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=159606753
The relatively untapped Asian region provides an array of growth opportunities for the blood culture test market. A large population base, rapid urbanization, increase in blood stream infection (BSI), rising prevalence of infectious diseases, rising aging population, increasing product availability and technological advancements are some of the factors responsible for the growth of this market.
To leverage these market opportunities and to reduce the manufacturing and distribution costs, various market players are building manufacturing facilities and strengthening their sales force in these developing economies. However, high cost of automated blood culture systems and lack of adequate reimbursement are hindering the growth of this market.
Apart from the comprehensive geographical analysis, product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the blood culture test market and their product portfolios, developments and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size and forecast of future trends will help key players and new entrants to make informed decisions regarding product offerings, geographical focus and change in strategic approach; R&D investments for innovations in products and technologies; and levels of output in order to remain successful.
Browse Related Reports:
Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019
http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html
Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.htm
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article